Dr Reddy's Laboratories on August 19 announced the launch of Avigan (Favipiravir) pills, used for treating mild to moderate COVID-19 sufferers in India.

<span style="color: #ff6600;"><a style="color: #ff6600;" href="https://www.news18.com/news/india/dr-reddys-launches-home-delivery-of-covid-19-treatment-drug-avigan-in-42-cities-2801861.html">Dr Reddy's stated Avigan was approved by the Drugs Controller General of India (DCGI) for treating patients with moderate to medium COVID-19.</a></span>

"The need for high efficacy and quality, affordability and improved disease control are essential priorities for us. We think that Avigan would offer an effective treatment alternative to the COVID-19 affected sufferers in India," M Ramana, CEO, Branded Markets (India and Emerging Markets), Dr Reddy's Laboratories, stated.